PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting. A 2-year regional lipid clinic experience
暂无分享,去创建一个
H. Milionis | E. Liberopoulos | M. Elisaf | G. Liamis | E. Christopoulou | G. Anastasiou | T. Dimitriou
暂无分享,去创建一个
H. Milionis | E. Liberopoulos | M. Elisaf | G. Liamis | E. Christopoulou | G. Anastasiou | T. Dimitriou